Scientists have identified two molecules, Sprouty 1 and Sprouty 2, that modify the survival of effector T cells and the development of memory CD8 T cells. Their findings offer promising potential for immunotherapeutic strategies to combat cancer and chronic infections.
from Top Health News -- ScienceDaily https://ift.tt/2BvBZwJ
No comments:
Post a Comment